Genalyte
Spectrum Solutions Saliva Collection Device, Access Bio, Genalyte Coronavirus Tests Get FDA EUAs
Spectrum Solutions' specimen collection device is used with SARS-CoV-2 saliva tests from DxTerity Diagnostics and RUCDR Infinite Biologics.
The company said this week that is has raised $36 million in funding, as it continues efforts to develop its Maverick platform for rapid testing in doctors' offices.
Genalyte Raises $36M in Funding
The company said it will use the funds to further refine its Maverick Detection System for rapid blood testing in outpatient settings like doctors' offices.
Genalyte to Use $44M Funding Round to Pursue FDA Clearance for Multiplexed Immunoassay Device
Premium
The company is preparing a clinical study through which it will collect data that it will use to submit the device to FDA for 510(k) clearance next year.
Genalyte Raises $44M in Series C Financing
The San Diego diagnostics firm's technology is designed for rapid, multiplexed, blood-based testing in a physician's office setting.
Jan 20, 2015
Sep 3, 2013
Aug 16, 2013
Apr 12, 2013
Sep 19, 2012
Genalyte, Scienion Ink Marketing Pact
Jul 27, 2012